NCT00064324View on ClinicalTrials.gov

Perifosine in Treating Patients With Advanced Soft Tissue Sarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

November 30, 2005

Conditions
Recurrent Adult Soft Tissue SarcomaStage III Adult Soft Tissue SarcomaStage IV Adult Soft Tissue Sarcoma
Interventions
DRUG

perifosine

Given orally

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

pharmacological study

Correlative studies

Trial Locations (1)

55905

Mayo Clinic, Rochester

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00064324 - Perifosine in Treating Patients With Advanced Soft Tissue Sarcoma | Biotech Hunter | Biotech Hunter